Skip to main content


04-05-2023 | Flash glucose monitoring | News

Reduced acute complications for young people using CGM

Data from the DPV cohort show a reduced risk for severe hypoglycemia and diabetic ketoacidosis among children and young people with type 1 diabetes using continuous glucose monitoring rather than self-monitored blood glucose.

03-30-2023 | Artificial pancreas systems | News

Virtual closed-loop initiation success in very young children

The Tandem Control-IQ system delivers improved glucose control versus standard care in children with type 1 diabetes aged between 2 and 6 years and can be initiated virtually, report researchers.

03-21-2023 | Diabetes prevention | News

Verapamil promising for preserving beta-cell function in children

Two linked randomized trials published in JAMA support a role for verapamil, but not for intensive glycemic control, to slow C-peptide decline in children with newly diagnosed type 1 diabetes.

01-26-2023 | Screening | News

Age 10 years is optimal type 1 diabetes screening point for adolescents

“Almost no one” who is islet autoantibody negative at age 10 years despite a high familial risk for type 1 diabetes will develop clinical diabetes by the age of 18, report researchers.

11-30-2022 | Artificial pancreas systems | News

Real-world data show reduced diabetes burden in young closed-loop users

Real-world use of hybrid closed-loop insulin delivery is associated with improved glycemic control and sleep quality, as well as reduced fear of hypoglycemia in children and young people with type 1 diabetes, shows a UK study.

11-22-2022 | Dulaglutide | News

FDA clears dulaglutide for adolescents

Click through to read more on this announcement

11-18-2022 | Teplizumab | News

FDA clearance for teplizumab to slow type 1 diabetes onset

Click through to read more on this announcement

11-16-2022 | Epidemiology | News

Modeling suggests substantial underdiagnosis of childhood type 1 diabetes

Nearly half of all cases of type 1 diabetes occurring annually in children and adolescents may go undiagnosed, especially in low- and middle-income countries, show the results of a modeling study.